Here are relevant reports on : ophthalmic-drugs-market
-
Ophthalmic Equipment Market by Technology (AI-enabled Equipment), Product Type (Surgical Devices (Ophthalmic Microscopes), Diagnostic & Monitoring Devices (Optical Coherence Tomography Scanners, Slit Lamps) ), End User (Hospitals) - Global Forecast to 2030
The global ophthalmic equipment market, valued at US$18.61 billion in 2024, stood at US$19.65 billion in 2025 and is projected to advance at a resilient CAGR of 5.9% from 2024 to 2030, culminating in a forecasted valuation of US$26.14 billion by the end of the period.
- Published: November 2025
- Price: $ 7150
- TOC Available:
-
Ophthalmic Imaging Market by Product Type (Optical Coherence Tomography Systems, Ophthalmic Ultrasound Systems, Fundus Cameras), Application (Glaucoma, Retinopathies), End User (Hospitals, Ophthalmology Clinics, Optometry Clinics) - Global Forecast to 2030
The global ophthalmic imaging market, valued at US$2.7 billion in 2024, stood at US$2.8 billion in 2025 and is projected to advance at a resilient CAGR of 6.3% from 2025 to 2030, culminating in a forecasted valuation of US$3.8 billion by the end of the period. The ophthalmic imaging market is driven by the rising prevalence of eye diseases and an aging global population, which boosts demand for advanced diagnostic tools.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Ophthalmic Diagnostic and Surgical Devices Market (2012-2017)
The report studies the ophthalmology devices market by diagnostic devices and surgical devices. This market is expected to witness significant growth due to the increasing incidence and prevalence of eye related disorders such as presbyopia, macular degeneration, and diabetic retinopathy among the aging population. With the introduction of ophthalmic devices equipped with sophisticated technologies, people are increasingly opting for ophthalmic surgeries to correct their eye related disorders.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Ophthalmic Surgical Technologies — (2012-2017)
Advanced medical facilities have helped increased the life expectancy that in turn demands that there should be constant development in the technologies and treatments of various illnesses. This report studies the advances made in the surgical treatment of the patients afflicted with the common eye diseases. It provides information on the latest and future technologies and surgical tools besides giving a detailed market data across products and geographies.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Therapeutic Drug Monitoring Market by Product (Equipments,Consumables), Technology (Immunoassays), Drug Class (Anti–Epileptic Drugs,Anti–Arrhythmic Drugs), Therapeutic Area (Oncology, Cardiology), Specimen (Blood), End user - Global Forecast to 2029
The global therapeutic drug monitoring market, valued at US$2.14 billion in 2023, stood at US$2.30 billion in 2024 and is projected to advance at a resilient CAGR of 8.4% from 2024 to 2029, culminating in a forecasted valuation of US$3.44 billion by the end of the period. This growth is brought on by a number of causes, such as the rise in chronic diseases like cancer, heart disease, epilepsy, and autoimmune conditions.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Epigenetic Drugs & Diagnostics Market - Global Forecast to 2030
Epigenetic Drugs & Diagnostics Market
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Thrombosis Drugs Market by Type, Product, End-Use Industry and Region - Global Forecast to 2033
Thrombosis drugs refer to medications that are used to prevent or treat blood clots that form inside blood vessels, which can lead to serious medical conditions such as heart attack, stroke, deep vein thrombosis (DVT), and pulmonary embolism (PE). These drugs work by either preventing the formation of clots (anticoagulants) or dissolving existing clots (thrombolytics). The market for thrombosis drugs includes both prescription and over-the-counter medications.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Diabetes Market (Devices and Drugs)
Sedentary lifestyle has led to the increase in diabetic patients and increasing awareness of side effects caused if left undiagnosed has increased the number of patients turning out for diagnosis and regular check. Additionally diabetes devices has also been a leading market in home healthcare segment as well, with introduction of handy glucose monitors. The market is evidencing continued innovation addressing issues pertaining to painless and user friendly diagnostic devices, drugs with less side effects, Insulin delivery systems etc. The market dynamics in this industry compels the competitors to be aware of the competitive moves to enhance market revenues and retain market share
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
BRIC Diabetes Drugs Market (2010-2015) in Brazil, Russia, India, China
The prevalence of diabetes is increasing globally with the increase in life expectancy and rising incidence of obesity. Brazil’s diabetes drugs market is showing a double digit growth rate; while the Russian insulin market is also expected to witness significant growth with an estimated over 20 million patients in the region requiring diabetes treatment by 2025. India and China have the highest number of diabetics in the world – China alone is expected to have more than 71 million diabetic patients by 2025; and the similarly huge patient-base in India has already attracted a number of pharmaceutical companies such as Eli Lilly and Novo Nordisk. These companies are offering easy-to-use insulin versions to grab the market share in the Indian market for diabetes drugs. Thus, diabetes drugs market in BRIC economies is expected to have significant growth opportunities in the years to come.
- Published: April 2010
- Price: $ 4950
- TOC Available:
-
Global Breast Cancer Drugs Market
There are about one million new cases of breast cancer every year. Breast cancer accounts for about 10% of world wide cancer. There has been significant increase in awareness levels with respect to impact on survival rates incase of early diagnosis. Therefore, opening novel opportunities for breast cancer drugs market.
- Published: February 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
